ArticleScientific reports2025
Association of KCNJ11 rs5219 polymorphism with risk of type 2 diabetes and its cardiovascular and renal complications in Noakhali, Bangladesh.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 2 diabetes mellitus (T2DM) is a rising worldwide health concern, with an estimated 366 million cases by 2030 including 11.1 million in Bangladesh. The KCNJ11 (rs5219) polymorphism has been associated with T2DM in different populations, but its role in T2DM in Bangladesh remains quite unexplored. This study explores the genetic association between the KCNJ11 (rs5219) and T2DM and its relationship to CVD and CKD in the Bangladeshi population. A case-control study was conducted in Noakhali, Bangladesh where genomic and biochemical analyses were performed, including serum creatine, lipid profile and blood glucose levels. DNA was analyzed using ARMS-PCR and gel electrophoresis. The TT genotype was more prevalent in T2DM (68.2%), CVD (67.2%), and CKD (62.5%) groups. Significant associations (p < 0.05) were found between genotype and metabolic markers. The CT genotype in diabetic patients was showed increased risks for BMI (OR 3.43; 95% CI 1.07-1.91). For CVD patients, the TT genotype imposed higher risks for C-reactive protein (OR 1.3; 95% CI 0.79-2.03). For CKD patients, the TT genotype showed higher risk (OR 1.9; 95% CI 0.81-1.62) for serum creatinine as well as with some other parameters. The KCNJ11 (rs5219) polymorphism is significantly associated to T2DM and its complications in Bangladesh.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.